Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study

Abstract : Early and late Sestamibi studies were acquired in addition to conventional MRI protocol in 14 patients with high-grade gliomas to monitor an antiangiogenic treatment. Global and local indices were deduced from these SPECT studies and were compared with progression free survival (PFS) and overall survival (OS). Variations of intensity in late studies were not correlated with PFS, but were related to OS. This suggests the possible role of Sestamibi for monitoring response to treatment.
Type de document :
Communication dans un congrès
Journées RITS 2015, Mar 2015, Dourdan, France. Actes des Journées RITS 2015, pp.48-49, 2015
Liste complète des métadonnées

Littérature citée [2 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01143772
Contributeur : Nathalie Duchange <>
Soumis le : lundi 20 avril 2015 - 11:03:40
Dernière modification le : vendredi 31 août 2018 - 09:03:58
Document(s) archivé(s) le : mercredi 19 avril 2017 - 00:13:15

Fichier

ACTES-RITS2015-HALp48-49.pdf
Fichiers produits par l'(les) auteur(s)

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

  • HAL Id : inserm-01143772, version 1

Citation

Jean-Marc Tacchella, Nathanaelle Yeni, Gregorio Petrirena, Mike-Ely Cohen, Muriel Lefort, et al.. Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study. Journées RITS 2015, Mar 2015, Dourdan, France. Actes des Journées RITS 2015, pp.48-49, 2015. 〈inserm-01143772〉

Partager

Métriques

Consultations de la notice

237

Téléchargements de fichiers

386